P
About
Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing — a revolutionary gene editing approach developed to find and correct disease-causing genetic sequences at their precise genomic location without inducing double-strand DNA breaks. Unlike traditional gene editing tools, Prime Editing functions like a DNA word processor, enabling versatile, precise, and efficient correction of virtually all classes of genetic mutations across a broad range of organs, cell types, and organisms. The company believes Prime Editing can theoretically address around 90% of known disease-causing mutations, positioning it as one of the most broadly applicable gene editing platforms in development. Prime Medicine is advancing a pipeline of clinical programs targeting serious genetic diseases, with a commitment to providing patients potentially lifelong cures. Its proprietary PASSIGE delivery technology and Dual Flap editing capabilities further enhance the platform's reach and efficiency. The company is built by a team of dedicated scientists and researchers who are passionate about reshaping how genetic disease is treated, aiming to offer long-lasting therapeutic benefit to patients worldwide.
Key Features
- Search-and-Replace Gene Editing: Prime Editing locates the exact genomic site of a faulty DNA sequence and replaces it with a correct copy, without causing double-strand DNA breaks.
- Broad Mutation Coverage: The platform is theoretically capable of addressing ~90% of known disease-causing mutations across many organisms, organs, and cell types.
- Dual Flap Technology: An advanced editing configuration that enhances the precision and efficiency of genetic corrections at targeted genomic sequences.
- PASSIGE Delivery Platform: Prime Medicine's proprietary delivery technology designed to expand the reach and in vivo applicability of Prime Editing therapeutics.
- Versatile Mutation Targeting: Designed to work across most types of gene mutations at their natural genomic location while minimizing unwanted off-target DNA modifications.
Use Cases
- Developing curative gene therapies for rare monogenic diseases by correcting the causative mutation at its precise genomic location.
- Advancing clinical programs targeting life-limiting genetic conditions where no effective treatments currently exist.
- Researching and validating Prime Editing delivery mechanisms for in vivo therapeutic applications across diverse tissue types.
- Enabling biotech and pharmaceutical partners to leverage the Prime Editing platform for collaborative drug development.
- Supporting pre-screening studies and patient identification for upcoming gene editing clinical trials.
Pros
- Unprecedented Precision: Prime Editing corrects mutations at their exact genomic location without inducing double-strand breaks, reducing the risk of off-target effects compared to older editing methods.
- Broad Therapeutic Applicability: The platform's ability to address ~90% of known disease-causing mutations makes it applicable to a wide range of genetic diseases.
- Potentially Curative Outcomes: By addressing the genetic root cause of disease, Prime Editing therapies have the potential to provide patients with long-lasting or lifelong benefit.
Cons
- Early Clinical Stage: Most programs are still in early clinical or pre-clinical development, meaning broad patient access and proven outcomes are still years away.
- Complex Delivery Challenges: Delivering gene editing machinery efficiently and safely to specific tissues in vivo remains a significant technical and manufacturing challenge.
- Limited Public Data: As a clinical-stage company, detailed efficacy and safety data from human trials are still limited and emerging.
Frequently Asked Questions
What is Prime Editing?
Prime Editing is a next-generation gene editing technology that acts like a DNA word processor, enabling precise 'search and replace' of disease-causing genetic sequences at their exact location in the genome without causing double-strand DNA breaks.
What diseases does Prime Medicine target?
Prime Medicine is developing therapies for serious genetic diseases. The platform is theoretically capable of addressing ~90% of known disease-causing mutations, covering a broad range of conditions across multiple organ systems.
How is Prime Editing different from CRISPR?
Unlike traditional CRISPR, Prime Editing does not require double-strand DNA breaks or separate DNA donor templates. It uses a modified Cas9 and a prime editing guide RNA to directly rewrite DNA sequences with greater precision and less risk of unintended edits.
What is PASSIGE?
PASSIGE is Prime Medicine's proprietary delivery technology, designed to efficiently and safely deliver Prime Editing components to target cells and tissues in vivo.
How can patients learn about Prime Medicine's clinical programs?
Patients and caregivers can visit the Patients & Caregivers section of the Prime Medicine website for information on current programs, the Prime-0211 Pre-screening Study, and external resources.
